Where Data Tells the Story
© Voronoi 2025. All rights reserved.
This graphic shows the forecasted value of the global obesity drug market, based on Morgan Stanley Research estimates.
The obesity drug market is expected to grow 5x by 2030, thanks to a number of factors like:
The majority of obesity drug revenue comes from the U.S., though its share of the global total is expected to decrease throughout this decade, from 77% in 2024 to 66% in 2030.